Company Valuation: Proteome Sciences plc

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 11.42 15.13 10.33 13.37 10.04 7.38
Change - 32.43% -31.71% 29.43% -24.94% -26.47%
Enterprise Value (EV) 1 20.25 24.43 18.25 24.82 23.43 22.37
Change - 20.62% -25.28% 35.98% -5.6% -4.53%
P/E 38.7x 258x 8.14x -5.46x -2.95x -2.4x
PBR -3.4x -5.45x -12.3x -4.36x -1.54x -0.77x
PEG - -3.2x 0x 0x -0.1x 0.24x
Capitalization / Revenue 2.4x 2.95x 1.33x 2.66x 2.05x 1.96x
EV / Revenue 4.26x 4.76x 2.35x 4.94x 4.79x 5.96x
EV / EBITDA 34.9x 54x 9.95x -16.6x -10.6x -9x
EV / EBIT 36.9x 59.3x 10.6x -15.3x -9.96x -8.39x
EV / FCF 19.6x 76.9x 25.2x -43.1x -42.4x -58.7x
FCF Yield 5.11% 1.3% 3.97% -2.32% -2.36% -1.7%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 0.000999 0.000199 0.004299 -0.008299 -0.0115 -0.0104
Distribution rate - - - - - -
Net sales 1 4.753 5.129 7.78 5.028 4.887 3.756
EBITDA 1 0.581 0.452 1.834 -1.498 -2.203 -2.486
EBIT 1 0.549 0.412 1.728 -1.621 -2.353 -2.666
Net income 1 0.295 0.072 1.325 -2.443 -3.406 -3.061
Net Debt 1 8.828 9.3 7.921 11.45 13.39 14.99
Reference price 2 0.0387 0.0512 0.0350 0.0453 0.0340 0.0250
Nbr of stocks (in thousands) 295,182 295,182 295,182 295,182 295,182 295,182
Announcement Date 4/8/21 A 4/14/22 A 4/3/23 A 4/20/24 A 4/18/25 A 4/20/26 A
1GBP in Million2GBP
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 8.52M
30.94x4.19x16.22x2.38% 187B
19.75x3.44x12.1x3.41% 112B
17.52x0.2x12.83x0.74% 61.15B
31.31x7.81x19.88x1.27% 54.39B
34.29x3.31x11.26x2.22% 48.17B
33.97x5.97x18.74x-.--% 31.98B
41.84x1.3x11.77x0.16% 30.91B
41.29x7.23x25.96x0.25% 24.92B
25.57x3.88x13.52x1.12% 23.15B
Average 30.72x 4.15x 15.81x 1.29% 57.28B
Weighted average by Cap. 28.64x 3.95x 15.20x 1.89%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. PRM Stock
  4. Valuation Proteome Sciences plc